Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ghorpade

Showing results (341-350 of 351) with videos related to

Pageof 36
Sort By:
EMBO Molecular Medicine|April 7, 2026
Integrating chemical, genetic, and feasibility assessments for anti-tubercular target validationDirk Schnappinger, Steven J Berthel, Helena I M Boshoff, et al.
Journal of Medicinal Chemistry|August 14, 2025
Novel Inhibitors of <i>Plasmodium</i> Phosphatidylinositol 4-kinase IIIβ with Low Propensity for Resistance: Life Cycle Stage Activity and <i>In Vivo</i> Efficacy in a Humanized Mouse Malaria Infection ModelGodwin A Dziwornu, Mmakwena M Mmonwa, Dina Coertzen, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2015
Whole cell screen based identification of spiropiperidines with potent antitubercular propertiesSubramanyam J Tantry, Giulia Degiacomi, Sreevalli Sharma, et al.
Journal of Medicinal Chemistry|August 20, 2021
1,3-Diarylpyrazolyl-acylsulfonamides as Potent Anti-tuberculosis Agents Targeting Cell Wall Biosynthesis in <i>Mycobacterium tuberculosis</i>Lutete Peguy Khonde, Rudolf Müller, Grant A Boyle, et al.
Journal of Medicinal Chemistry|January 4, 2021
Antitubercular 2-Pyrazolylpyrimidinones: Structure-Activity Relationship and Mode-of-Action StudiesCandice Soares de Melo, Vinayak Singh, Alissa Myrick, et al.
Bioorganic & Medicinal Chemistry Letters|January 11, 2014
Thiazolopyridone ureas as DNA gyrase B inhibitors: optimization of antitubercular activity and efficacyRamesh R Kale, Manoj G Kale, David Waterson, et al.
Journal of Medicinal Chemistry|October 4, 2013
Thiazolopyridine ureas as novel antitubercular agents acting through inhibition of DNA Gyrase BManoj G Kale, Anandkumar Raichurkar, Shahul Hameed P, et al.
Journal of Medicinal Chemistry|November 18, 2017
Novel Antitubercular 6-Dialkylaminopyrimidine Carboxamides from Phenotypic Whole-Cell High Throughput Screening of a SoftFocus Library: Structure-Activity Relationship and Target Identification StudiesColin R Wilson, Richard K Gessner, Atica Moosa, et al.
Journal of Medicinal Chemistry|June 25, 2024
2,8-Disubstituted-1,5-naphthyridines as Dual Inhibitors of <i>Plasmodium falciparum</i> Phosphatidylinositol-4-kinase and Hemozoin Formation with <i>In Vivo</i> EfficacyGodwin Akpeko Dziwornu, Donald Seanego, Stephen Fienberg, et al.
Journal of Medicinal Chemistry|May 30, 2014
4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activityMaruti Naik, Vaishali Humnabadkar, Subramanyam J Tantry, et al.
Pageof 36

Showing results (341-350 of 351) with videos related to

Sort By:
Pageof 36
EMBO Molecular Medicine|April 7, 2026
Integrating chemical, genetic, and feasibility assessments for anti-tubercular target validationDirk Schnappinger, Steven J Berthel, Helena I M Boshoff, et al.
Journal of Medicinal Chemistry|August 14, 2025
Novel Inhibitors of <i>Plasmodium</i> Phosphatidylinositol 4-kinase IIIβ with Low Propensity for Resistance: Life Cycle Stage Activity and <i>In Vivo</i> Efficacy in a Humanized Mouse Malaria Infection ModelGodwin A Dziwornu, Mmakwena M Mmonwa, Dina Coertzen, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2015
Whole cell screen based identification of spiropiperidines with potent antitubercular propertiesSubramanyam J Tantry, Giulia Degiacomi, Sreevalli Sharma, et al.
Journal of Medicinal Chemistry|August 20, 2021
1,3-Diarylpyrazolyl-acylsulfonamides as Potent Anti-tuberculosis Agents Targeting Cell Wall Biosynthesis in <i>Mycobacterium tuberculosis</i>Lutete Peguy Khonde, Rudolf Müller, Grant A Boyle, et al.
Journal of Medicinal Chemistry|January 4, 2021
Antitubercular 2-Pyrazolylpyrimidinones: Structure-Activity Relationship and Mode-of-Action StudiesCandice Soares de Melo, Vinayak Singh, Alissa Myrick, et al.
Bioorganic & Medicinal Chemistry Letters|January 11, 2014
Thiazolopyridone ureas as DNA gyrase B inhibitors: optimization of antitubercular activity and efficacyRamesh R Kale, Manoj G Kale, David Waterson, et al.
Journal of Medicinal Chemistry|October 4, 2013
Thiazolopyridine ureas as novel antitubercular agents acting through inhibition of DNA Gyrase BManoj G Kale, Anandkumar Raichurkar, Shahul Hameed P, et al.
Journal of Medicinal Chemistry|November 18, 2017
Novel Antitubercular 6-Dialkylaminopyrimidine Carboxamides from Phenotypic Whole-Cell High Throughput Screening of a SoftFocus Library: Structure-Activity Relationship and Target Identification StudiesColin R Wilson, Richard K Gessner, Atica Moosa, et al.
Journal of Medicinal Chemistry|June 25, 2024
2,8-Disubstituted-1,5-naphthyridines as Dual Inhibitors of <i>Plasmodium falciparum</i> Phosphatidylinositol-4-kinase and Hemozoin Formation with <i>In Vivo</i> EfficacyGodwin Akpeko Dziwornu, Donald Seanego, Stephen Fienberg, et al.
Journal of Medicinal Chemistry|May 30, 2014
4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activityMaruti Naik, Vaishali Humnabadkar, Subramanyam J Tantry, et al.
Pageof 36